MenQuadfi

Country: Evrópusambandið

Tungumál: finnska

Heimild: EMA (European Medicines Agency)

Virkt innihaldsefni:

Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid

Fáanlegur frá:

Sanofi Pasteur

ATC númer:

J07AH08

INN (Alþjóðlegt nafn):

meningococcal group A, C, W-135 and Y conjugate vaccine

Meðferðarhópur:

rokotteet

Lækningarsvæði:

Meningiitti, meningokokki

Ábendingar:

MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.

Vörulýsing:

Revision: 8

Leyfisstaða:

valtuutettu

Leyfisdagur:

2020-11-18

Upplýsingar fylgiseðill

504 GATEWAY TIME-OUT

Vara einkenni

504 GATEWAY TIME-OUT